ANCOTIL®

Composition

ANCOTIL® Tablet : Each tablet contains Bromazepam BP 3 mg.

Indication and Uses

Emotional Disturbances: Acute tension and anxiety states. Difficulties in interpersonal contact. Agitation, insomnia, anxious and agitated depressive reactions. Functional disturbances in the cardiovascular and respiratory systems: Pseudoangina precordial anxiety, tachycardia, emotiogenic hypertension, dyspnea and hyperventilation. In the gastrointestinal system: Irritable bowel syndrome, epigastria pain, spasm, bloating diarrhea etc. In the genitourinary system: Frequency, irritable bladder, and dysmenorrhea. Psychosomatic disorders: Psychogenic headache, psychogenic dermatosis, asthma, gastric and duodenal ulcer, and ulcerative colitis. Emotional reactions to chromic organic disease. Adjuvant to psychotherapy in psychoneurosis.

Dosage and Administration

Standard dosage: Average dosing for outpatient therapy: 1.5-3mg up to three times daily. Severe cases, especially in hospital; 6-12 mg two or three times daily. These amounts are general recommendations, and dosage should be individually determined. Treatment of outpatients should begin with low doses, gradually increasing to the optimum level. The duration of treatment should be as short as possible. The patient should be reassessed regularly and the need for continued treatment should be evaluated, especially in case the patient is symptom free. The overall treatment generally should not be more than 8-12 weeks, including a tapering off process. In certain cases extension beyond the maximum treatment period may be necessary, if so, it should not take place without re-evaluation of the patients status with special expertise. Special dosage instructions: Bromazepam is usually not indicated in children, but if the physician feels Bromazepam treatment is appropriate, then the dose should be adjusted to there low bodyweight (about 0.1-0.3 mg / kg bodyweight). Elderly patients and those with impaired hepatic function require flower doses because of individual variations in sensitivity and pharmacokinetics.